Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
GRN-1201 is a peptide cancer vaccine that targets four tumor associated antigens restricted to HLA-A2 to increase the activation of tumor-specific T cells (NCI Drug Dictionary).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|GRN-1201 + Pembrolizumab||GRN-1201 Pembrolizumab||0||1|